Vivo Capital IX, LLC

Average Profitability
21.69%
Insider Buys Quantity
4
Insider Buys Sum
$60.15M
Insider Sells Quantity
10
Insider Sells Sum
$21.99M

Insider Activity of Vivo Capital IX, LLC

The largest purchase of all time was on 2020-07-21 and amounted to 1950000 shares of ALX Oncology Holdings Inc. for $37.05M.

The largest sale of all time was on 2021-06-22 and amounted to 220000 shares of Tarsus Pharmaceuticals, Inc. for $6.27M.

Biography of Vivo Capital IX, LLC

No biography is available at this moment.

2023-08-09PurchaseIO Biotech, Inc.
IOBT
10 percent owner
3.16M
11.4408%
$1.90$6M-18.06%
2022-05-05SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
5,374
0.0225%
$12.25$65,832+25.23%
2022-05-04SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
19,738
0.0795%
$12.67$250,080+16.8%
2022-05-03SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
451,418
1.8836%
$13.25$5.98M+15.63%
2022-05-02SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
41,800
0.1864%
$15.19$634,942+7.64%
2021-11-09PurchaseIO Biotech, Inc.
IOBT
10 percent owner
650,000
15.7574%
$14.00$9.1M-62.27%
2021-06-25SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
15,408
0.0752%
$29.60$456,077-23.83%
2021-06-24SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
20,000
0.097%
$29.90$598,000-25.05%
2021-06-23SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
75,960
0.3632%
$29.80$2.26M-25.79%
2021-06-22SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
220,000
1.0703%
$28.50$6.27M-21.04%
2021-06-21SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
183,240
0.913%
$29.70$5.44M-22.33%
2021-04-14SaleTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
800
0.0039%
$30.37$24,296-16.73%
2020-10-20PurchaseTarsus Pharmaceuticals, Inc.
TARS
10 percent owner
500,000
6.0763%
$16.00$8M+36.85%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
10 percent owner
1.95M
4.0591%
$19.00$37.05M+90.48%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.